Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Rosuvastatin Calcium, Ezetimibe | Roneza | 4.4 Special Warnings and Special Precautions for Use | Myasthenia gravis and ocular myasthenia | Apr,2024 |
| Carbidopa monohydrate\Levodopa | Duodopa | 4.8. Undesirable effects | Addition of Urinary tract infections (frequency: very common) | Apr,2024 |
| Methylphenidate | Ritalin | 4.8. Undesirable effects | Epistaxis | Apr,2024 |
| Carbidopa / Levodopa | Sinemet | 4.8. Undesirable effects | Addition of Urinary tract infections (frequency: very common) | Apr,2024 |
| Epinephrine | EpiPen | 4.4 Special Warnings and Special Precautions for Use | Risk for adrenaline not reaching the muscle tissue resulting in a suboptimal effect patients with a thick sub-cutaneous fat layer | Apr,2024 |
| Isavuconazonium | Cresemba | "4.4. Special warnings and precautions for use 4.8 Undesirable effects" | "Anaphylactic reaction Immune system disord Aenrsa emia, not known Anaphylactic reaction" | Mar,2024 |